NYSE Flags Accendra Health for Sub-$1 Share Price; Reverse Split on Table
ACH is trading near its 52-week low of $0.42 (1.9% above the low).
Summary
Accendra Health received an NYSE continued listing standard notice on October 6, 2026, because its Class A common stock averaged below $1.00 over a consecutive 30 trading-day period, violating Section 802.01C of the NYSE's Listed Company Manual. The stock currently trades at $0.428, near its 52-week low of $0.42. To regain compliance, the stock must have a closing price of at least $1.00 and an average closing price of at least $1.00 over the 30 trading days ending on the last day of a calendar month or the cure period, and the company must notify the NYSE of its intent to cure within 10 business days of receiving the notice. The company has six months to regain compliance and is considering a reverse stock split, which would require stockholder approval at the May 2027 annual meeting. This follows a Q2 loss of $1.16 per share, cash reserves of just $7.7 million, and a $200M shelf registration filed in July. The notice does not immediately delist the stock and does not affect the company's business operations or its reporting obligations with the Securities and Exchange Commission, but it adds pressure to an already distressed equity story.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — Accendra Health must notify the NYSE of its intent to cure within 10 business days and achieve a $1.00 closing and 30-day average price to regain compliance.
- Listing Standard Violated — The specific NYSE listing standard violated is Section 802.01C of the NYSE's Listed Company Manual.
- Compliance Requirements — To regain compliance, the stock must have a closing price of at least $1.00 and an average closing price of at least $1.00 over the 30 trading days ending on the last day of a calendar month or the cure period.
- Intent to Cure Deadline — The company must notify the NYSE of its intent to cure within 10 business days of receiving the notice.
- No Operational Impact — The Notice does not affect the Company’s business operations or its reporting obligations with the Securities and Exchange Commission.
All 4 details
- The specific NYSE listing standard violated is Section 802.01C of the NYSE's Listed Company Manual.
- To regain compliance, the stock must have a closing price of at least $1.00 and an average closing price of at least $1.00 over the 30 trading days ending on the last day of a calendar month or the cure period.
- The company must notify the NYSE of its intent to cure within 10 business days of receiving the notice.
- The Notice does not affect the Company’s business operations or its reporting obligations with the Securities and Exchange Commission.
At the time of this announcement, ACH was trading at $0.43 on NYSE in the Trade & Services sector, with a market capitalization of approximately $32.9M. The 52-week trading range was $0.42 to $5.60. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: BusinessWire.